VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 72 filers reported holding VOR BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $95,367 | -67.0% | 95,367 | +77.4% | 0.00% | -100.0% |
Q1 2023 | $289,148 | +119.2% | 53,745 | +171.0% | 0.00% | 0.0% |
Q4 2022 | $131,896 | +123.6% | 19,834 | +33.7% | 0.00% | – |
Q3 2022 | $59,000 | -27.2% | 14,834 | -9.0% | 0.00% | -100.0% |
Q2 2022 | $81,000 | -64.2% | 16,297 | -56.5% | 0.00% | -50.0% |
Q1 2022 | $226,000 | -55.6% | 37,439 | -14.6% | 0.00% | -50.0% |
Q4 2021 | $509,000 | +131.4% | 43,819 | +212.9% | 0.00% | +33.3% |
Q3 2021 | $220,000 | -43.7% | 14,005 | +54.5% | 0.00% | -50.0% |
Q1 2021 | $391,000 | – | 9,065 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,692,429 | $124,814,000 | 31.41% |
Trustees of Columbia University in the City of New York | 183,821 | $3,428,000 | 5.06% |
RA Capital Management | 11,120,973 | $207,406,000 | 3.33% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $20,042,000 | 2.05% |
Sarissa Capital Management LP | 707,010 | $13,186,000 | 1.05% |
SECTORAL ASSET MANAGEMENT INC | 405,324 | $7,559,000 | 0.61% |
Woodline Partners LP | 1,146,494 | $21,382,000 | 0.40% |
Artal Group S.A. | 550,000 | $10,258,000 | 0.21% |
NEXPOINT ASSET MANAGEMENT, L.P. | 50,000 | $933,000 | 0.20% |
Orbimed Advisors | 833,333 | $15,542,000 | 0.16% |